Drug Profile
ASP 0892
Alternative Names: ARA h1,2,3-Lamp-vax peanut vaccine; ARA-LAMP-Vax™; ASP0892; Peanut allergy vaccine - ImmunomicLatest Information Update: 11 Nov 2021
Price :
$50
*
At a glance
- Originator Immunomic Therapeutics
- Developer Astellas Pharma
- Class DNA vaccines; Food allergy immunotherapies
- Mechanism of Action Th1 cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Peanut hypersensitivity
Most Recent Events
- 11 Oct 2021 Astellas Pharma completes a phase I trial in Peanut hypersensitivity (Prevention) (In Adolescents)in USA (Intradermal) (NCT03755713)
- 30 Jun 2021 Discontinued - Phase-I for Peanut hypersensitivity (In adolescents, Prevention) in USA (Intradermal)
- 30 Jun 2021 Discontinued - Phase-I for Peanut hypersensitivity (Prevention) in USA (IM)